Lung transplant for stage IV lung cancer achieved 100% one-year survival in 17 NSCLC patients in a landmark JAMA study from ...
Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...
Oral cancer, predominantly oral squamous cell carcinoma (OSCC), remains a significant global health burden with high morbidity and mortality. Despite ...
Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...
A new Northwestern Medicine study has discovered how radiotherapy alters the immune environment within cutaneous T-cell ...
The gut microbiome is no longer viewed as a mere spectator in cancer development – it is increasingly recognized as a key ...
High-resolution spatial transcriptomics and imaging-based technologies are now generating large-scale, multi-dimensional datasets that are beginning to reshape how we understand tissue organisation, ...
As scientists gain a deeper understanding of how the body’s immune system remembers pathogens it must fight, the paradigm for ...
Acute myeloid leukemia (AML) does more than infiltrate the lungs: it also transforms lung tissue to create an inflammatory ...
Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue and cause ...
Led by NYU Langone Health researchers, a new study shows how blood cancer cells enter the lungs, damage tissue, and cause ...
Welltica+ on MSN
FDA-approved drug shows promise against liver cancer
Researchers found that an existing FDA-approved drug could make immunotherapy more effective against a rare form of liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results